Unity Is Strength: The Mutual Alliance between CFTR and SLC26A6 as Therapeutic Opportunity in Cystic Fibrosis
Patients with cystic fibrosis (PwCF) have recently experienced an unprecedented breakthrough with the adoption of modulator therapy in clinical practice. This remarkable achievement has led to the reconsideration of disease management as the increased life expectancy has gradually shifted the attent...
Saved in:
Main Authors: | Marilena Pariano (Author), Cinzia Antognelli (Author), Luigina Romani (Author), Claudio Costantini (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2024-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Bacteria and fungi of the lung: allies or enemies?
by: Enrico Garaci, et al.
Published: (2024) -
CFTR and Ca2+ signaling in cystic fibrosis
by: Fabrice eAntigny, et al.
Published: (2011) -
Strategies to circumvent the CFTR defect in cystic fibrosis
by: Frederic eBecq, et al.
Published: (2013) -
Nutritional impact of CFTR modulators in children with cystic fibrosis
by: Margaux Gaschignard, et al.
Published: (2023) -
Inflammation and CFTR: Might Neutrophils be the Key in Cystic Fibrosis?
by: V. Witko-Sarsat, et al.
Published: (1999)